Cigna joins the VC fray with new $250 million venture fund
Cigna competitors who have launched their own venture arms include Humana, Kaiser Permanente and UnitedHealthGroup's Optum division.
Prognos raises $20.5 million from investors including Cigna, Merck Global Health Innovation Fund
Prognos, a New York City-based artificial intelligence company, has wrapped up a $20.5 million Series C financing round from investors such as Cigna, Merck Global Health Innovation Fund, Hermed, Hikma Ventures, GIS Strategic Ventures, Maywic and Safeguard Scientifics.
presented by
Enhanced Direct Enrollment: Georgia Access and the Power of Partnership
Across the nation, state-based health insurance exchanges are searching for ways to better serve their communities while making enrollment easier, more personal, and more accessible for everyone.
Rebranded healthcare AI company Prognos goes after payer market
As part of the relaunch, New York-based Prognos is making an aggressive push into the payer market to augment its predictive analytics work with life sciences and diagnostics clients.